Mylan Reaches $2.6M Deal In Mass. Medicaid Case
Mylan Inc. has coughed up $2.6 million to settle a lawsuit alleging it and several other drugmakers reported false and inflated prices for generic pharmaceutical products paid for by the Massachusetts...To view the full article, register now.
Already a subscriber? Click here to view full article